Multisystem inflammatory syndrome in children (MIS-C) possibly secondary to COVID-19 mRNA vaccination
Authors:
Open Access
- 29 March 2022
- journal article
- research article
- Published by BMJ in BMJ Case Reports
- Vol. 15 (3) , e247176
Abstract
Multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 is a postinfectious condition identified during the COVID-19 pandemic with specific Centers for Disease Control and Prevention and WHO criteria. Theoretical concerns have been raised whether MIS-C might also occur after COVID-19 vaccination, as the pathogenesis of MIS-C is not yet entirely understood. We present a woman in her late teens who developed MIS-C after having received two doses of Pfizer BioNTech COVID-19 vaccine 12 weeks prior, in the setting of documented anti-spike SARS-CoV-2 IgG positive, antinucleocapsid SARS-CoV-2 IgG negative, and multiple negative surveillance SARS-CoV-2 PCRs done in the 12-week period prior to development of MIS-C. While vaccination remains safe and critical in controlling the pandemic, it may be considered as a potential trigger for MIS-C in patients with no history of infection. Further surveillance is necessary to determine whether MIS-C will emerge as a confirmed adverse event after COVID-19 vaccination.Keywords
This publication has 21 references indexed in Scilit:
- Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS–CoV-2Journal of Clinical Investigation, 2020
- COVID-19–Associated Multisystem Inflammatory Syndrome in Children — United States, March–July 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 PandemicCirculation, 2020
- Multisystem Inflammatory Syndrome in U.S. Children and AdolescentsNew England Journal of Medicine, 2020
- Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2JAMA, 2020
- An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort studyThe Lancet, 2020
- Hyperinflammatory shock in children during COVID-19 pandemicThe Lancet, 2020
- Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart AssociationCirculation, 2017
- Kawasaki disease: update on pathogenesisCurrent Opinion in Rheumatology, 2010
- Viral MyocarditisCirculation, 2009